Can GE HealthCare’s Allia upgrades modernize interventional suites without full replacement?
Find out how GE HealthCare’s Allia upgrade pathways could modernize aging interventional suites while limiting downtime and construction.
Find out how GE HealthCare’s Allia upgrade pathways could modernize aging interventional suites while limiting downtime and construction.
CUC America is expanding MSK embolization through office-based labs. Read what this means for genicular artery embolization adoption and pain care scale-up.
InterVene has completed 30 Recana cases, raising new questions about venous ISR treatment, adoption, and launch strategy. Read the full analysis.
Gore’s VIATORR device earns CE mark for 6–10 mm range, enabling tailored TIPS procedures. Find out how this could reshape portal hypertension care.
Bendit Technologies has secured 510(k) clearance from the U.S. Food and Drug Administration for its Bendit17 steerable microcatheter, a device the company describes as the smallest steerable microcatheter available for use in neurovascular and peripheral endovascular interventions. With U.S. commercialization slated to begin in January 2026, the Israel-based medical device manufacturer is also pursuing regulatory
Philips expands LumiGuide AI 3D light-based navigation across US and Europe. Find out how it could reshape image-guided therapy without radiation.